$9.85 Billion is the total value of Bellevue Group AG's 265 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 10.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRNA | Sell | MODERNA INC | $664,787,000 | +11.3% | 1,727,349 | -32.1% | 6.75% | +15.7% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $313,529,000 | -20.8% | 9,347,926 | -5.9% | 3.18% | -17.7% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $288,119,000 | -1.9% | 3,004,051 | -0.5% | 2.92% | +2.0% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $265,924,000 | +1.3% | 1,408,418 | -9.1% | 2.70% | +5.3% |
| INCY | Sell | INCYTE CORP | $203,383,000 | -18.6% | 2,957,000 | -0.5% | 2.06% | -15.4% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $200,383,000 | -16.5% | 4,341,992 | -0.3% | 2.03% | -13.2% |
| BIIB | Sell | BIOGEN INC | $149,136,000 | -18.4% | 527,000 | -0.2% | 1.51% | -15.2% |
| DHR | Sell | DANAHER CORPORATION | $139,031,000 | +7.3% | 456,679 | -5.4% | 1.41% | +11.5% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $132,063,000 | -3.9% | 337,982 | -1.5% | 1.34% | -0.1% |
| BDX | Sell | BECTON DICKINSON & CO | $111,989,000 | -0.1% | 455,572 | -1.2% | 1.14% | +3.8% |
| AXNX | Sell | AXONICS INC | $104,716,000 | -4.6% | 1,608,794 | -7.0% | 1.06% | -0.7% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $98,487,000 | +6.8% | 869,951 | -2.3% | 1.00% | +11.0% |
| SWAV | Sell | SHOCKWAVE MED INC | $95,579,000 | -2.5% | 464,247 | -10.2% | 0.97% | +1.4% |
| EVH | Sell | EVOLENT HEALTH INCcl a | $94,013,000 | +22.3% | 3,032,678 | -16.6% | 0.95% | +27.2% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $77,095,000 | -21.2% | 1,302,934 | -11.0% | 0.78% | -18.1% |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $75,762,000 | +14.1% | 2,294,425 | -0.1% | 0.77% | +18.7% |
| CNC | Sell | CENTENE CORP DEL | $71,940,000 | -28.8% | 1,154,545 | -16.7% | 0.73% | -26.0% |
| HOLX | Sell | HOLOGIC INC | $64,264,000 | +5.4% | 870,662 | -4.7% | 0.65% | +9.6% |
| HRC | Sell | HILL-ROM HLDGS INC | $63,107,000 | -17.6% | 420,716 | -37.6% | 0.64% | -14.3% |
| GBIO | Sell | GENERATION BIO CO | $61,977,000 | -7.0% | 2,472,180 | -0.2% | 0.63% | -3.4% |
| EXEL | Sell | EXELIXIS INC | $60,439,000 | +13.1% | 2,859,000 | -2.5% | 0.61% | +17.7% |
| MOH | Sell | MOLINA HEALTHCARE INC | $45,649,000 | -9.2% | 168,255 | -15.3% | 0.46% | -5.7% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $45,591,000 | +16.6% | 416,200 | -0.4% | 0.46% | +21.2% |
| CI | Sell | CIGNA CORP NEW | $43,597,000 | -28.4% | 217,812 | -15.2% | 0.44% | -25.6% |
| SILK | Sell | SILK RD MED INC | $43,015,000 | -30.5% | 781,660 | -39.6% | 0.44% | -27.6% |
| MDT | Sell | MEDTRONIC PLC | $42,509,000 | -4.8% | 339,125 | -5.7% | 0.43% | -1.1% |
| GH | Sell | GUARDANT HEALTH INC | $42,490,000 | -9.9% | 339,894 | -10.5% | 0.43% | -6.3% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $37,487,000 | -62.9% | 921,500 | -58.6% | 0.38% | -61.5% |
| TFX | Sell | TELEFLEX INCORPORATED | $36,833,000 | -8.5% | 97,818 | -2.3% | 0.37% | -4.8% |
| HCAT | Sell | HEALTH CATALYST INC | $36,369,000 | -13.1% | 727,233 | -3.5% | 0.37% | -9.6% |
| BIO | Sell | BIO RAD LABS INCcl a | $34,325,000 | -39.0% | 46,015 | -47.3% | 0.35% | -36.6% |
| ABBV | Sell | ABBVIE INC | $30,516,000 | -16.4% | 282,900 | -12.7% | 0.31% | -12.9% |
| QTRX | Sell | QUANTERIX CORP | $29,566,000 | -21.0% | 593,819 | -6.9% | 0.30% | -17.8% |
| ILMN | Sell | ILLUMINA INC | $28,445,000 | -20.2% | 70,130 | -6.9% | 0.29% | -17.0% |
| TDOC | Sell | TELADOC HEALTH INC | $27,379,000 | -36.2% | 215,906 | -16.3% | 0.28% | -33.7% |
| NEO | Sell | NEOGENOMICS INC | $27,096,000 | -26.7% | 561,683 | -31.4% | 0.28% | -23.8% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $26,134,000 | -60.4% | 63,329 | -64.5% | 0.26% | -58.9% |
| AMWL | Sell | AMERICAN WELL CORPcl a | $19,385,000 | -28.1% | 2,127,838 | -0.6% | 0.20% | -25.1% |
| TMDX | Sell | TRANSMEDICS GROUP INC | $19,226,000 | -20.6% | 581,029 | -20.4% | 0.20% | -17.4% |
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $14,488,000 | -9.5% | 286,556 | -26.6% | 0.15% | -5.8% |
| CVS | Sell | CVS HEALTH CORP | $13,454,000 | +0.7% | 158,548 | -1.0% | 0.14% | +5.4% |
| OSCR | Sell | OSCAR HEALTH INCcl a | $11,824,000 | -20.8% | 679,952 | -2.0% | 0.12% | -17.8% |
| IMAB | Sell | I MABsponsored ads | $11,813,000 | -23.3% | 162,957 | -11.2% | 0.12% | -20.0% |
| INGN | Sell | INOGEN INC | $10,435,000 | -43.0% | 242,174 | -13.8% | 0.11% | -40.8% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $8,349,000 | -71.1% | 23,000 | -72.7% | 0.08% | -69.9% |
| AMGN | Sell | AMGEN INC | $7,219,000 | -77.1% | 33,950 | -73.8% | 0.07% | -76.3% |
| GKOS | Sell | GLAUKOS CORP | $6,930,000 | -83.5% | 143,870 | -71.0% | 0.07% | -82.9% |
| SYNH | Sell | SYNEOS HEALTH INCcl a | $4,986,000 | -21.0% | 57,000 | -19.1% | 0.05% | -17.7% |
| JNJ | Sell | JOHNSON & JOHNSON | $4,926,000 | -3.5% | 30,500 | -1.6% | 0.05% | 0.0% |
| BNTX | Sell | BIONTECH SEsponsored ads | $3,467,000 | -31.5% | 12,700 | -43.8% | 0.04% | -28.6% |
| SNY | Sell | SANOFIsponsored adr | $3,230,000 | -9.8% | 67,000 | -1.5% | 0.03% | -5.7% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $2,431,000 | -30.4% | 17,500 | -51.4% | 0.02% | -26.5% |
| CDNA | Sell | CAREDX INC | $1,961,000 | -85.6% | 30,943 | -79.2% | 0.02% | -85.0% |
| XNCR | Sell | XENCOR INC | $1,702,000 | -7.0% | 52,100 | -1.9% | 0.02% | -5.6% |
| KURA | Sell | KURA ONCOLOGY INC | $1,077,000 | -10.9% | 57,500 | -0.9% | 0.01% | -8.3% |
| CLLS | Sell | CELLECTIS S Aspon ads | $1,040,000 | -19.5% | 82,500 | -1.2% | 0.01% | -15.4% |
| OPT | Sell | OPTHEA LTDsponsored ads | $392,000 | -1.3% | 49,000 | -2.0% | 0.00% | 0.0% |
| RXRX | Exit | RECURSION PHARMACEUTICALS INcl a | $0 | – | -20,000 | -100.0% | -0.01% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -65,900 | -100.0% | -0.02% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -61,000 | -100.0% | -0.02% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -14,300 | -100.0% | -0.03% | – |
| SGFY | Exit | SIGNIFY HEALTH INC | $0 | – | -200,000 | -100.0% | -0.06% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -617,968 | -100.0% | -0.10% | – |
| EAR | Exit | EARGO INC | $0 | – | -434,054 | -100.0% | -0.17% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
- Bellevue Asset Management (UK) Ltd. #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.